EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 85 filers reported holding EDGEWISE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $122,353 | -23.3% | 21,353 | +3.7% | 0.00% | 0.0% |
Q2 2023 | $159,604 | +30.8% | 20,594 | +12.6% | 0.00% | 0.0% |
Q1 2023 | $122,021 | -23.9% | 18,294 | +2.0% | 0.00% | 0.0% |
Q4 2022 | $160,294 | +15.3% | 17,930 | +27.0% | 0.00% | 0.0% |
Q3 2022 | $139,000 | +25.2% | 14,113 | +1.4% | 0.00% | 0.0% |
Q2 2022 | $111,000 | -40.3% | 13,913 | -27.6% | 0.00% | 0.0% |
Q1 2022 | $186,000 | -40.8% | 19,210 | -6.6% | 0.00% | -50.0% |
Q4 2021 | $314,000 | +170.7% | 20,561 | +194.0% | 0.00% | +100.0% |
Q3 2021 | $116,000 | -21.1% | 6,993 | +1.1% | 0.00% | – |
Q2 2021 | $147,000 | – | 6,914 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |